Non-alcoholic fatty liver disease: a survey of involvement of primary care physicians.


Journal

Minerva gastroenterologica e dietologica
ISSN: 1827-1642
Titre abrégé: Minerva Gastroenterol Dietol
Pays: Italy
ID NLM: 9109791

Informations de publication

Date de publication:
Dec 2019
Historique:
pubmed: 28 10 2019
medline: 4 9 2020
entrez: 25 10 2019
Statut: ppublish

Résumé

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are neglected in most patients' electrical medical report by their family physicians (FP). We have assessed whether family physicians have the proper knowledge of NAFLD and accurate training to diagnose and treat NAFLD/NASH in overweight and obese patients. We conducted an anonymous survey questionnaire. Family Physicians who participated completed 4 years of residency and have passed the final examination. Our survey contained questions to measure the physician's attitudes, source of knowledge and recommendation regarding NAFLD/NASH treatment and attitudes toward patients with NAFLD/NASH. Categorical variables were extracted and analyzed using SPSS. A total of 310 of 422 FPs were included in the study with a compliance rate of 73%. Our data suggests that 167 of the 310 FPs (55%) refer their patients to a specialist for consultations if they exhibited fatty liver disease. Yet, 284 of 310 send their patients to consolations if exhibiting elevated liver enzyme. Our data significantly suggests that 241 of 310 (78%) reported that they have limited efficacy in treating NAFLD/NASH and consider themselves not properly prepared, by medical schools, to treat NASH/NAFLD patients; as well as patients with obesity and metabolic syndrome without fatty liver. FPs are more likely to neglect proper treatment for NAFLD/NASH due to lack of proper knowledge and are more likely neglect referring patients to specialist. Patients with significant obesity and obesity related conditions are more likely to have proactive treatment plans by their FPs.

Sections du résumé

BACKGROUND BACKGROUND
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are neglected in most patients' electrical medical report by their family physicians (FP). We have assessed whether family physicians have the proper knowledge of NAFLD and accurate training to diagnose and treat NAFLD/NASH in overweight and obese patients.
METHODS METHODS
We conducted an anonymous survey questionnaire. Family Physicians who participated completed 4 years of residency and have passed the final examination. Our survey contained questions to measure the physician's attitudes, source of knowledge and recommendation regarding NAFLD/NASH treatment and attitudes toward patients with NAFLD/NASH. Categorical variables were extracted and analyzed using SPSS.
RESULTS RESULTS
A total of 310 of 422 FPs were included in the study with a compliance rate of 73%. Our data suggests that 167 of the 310 FPs (55%) refer their patients to a specialist for consultations if they exhibited fatty liver disease. Yet, 284 of 310 send their patients to consolations if exhibiting elevated liver enzyme. Our data significantly suggests that 241 of 310 (78%) reported that they have limited efficacy in treating NAFLD/NASH and consider themselves not properly prepared, by medical schools, to treat NASH/NAFLD patients; as well as patients with obesity and metabolic syndrome without fatty liver.
CONCLUSIONS CONCLUSIONS
FPs are more likely to neglect proper treatment for NAFLD/NASH due to lack of proper knowledge and are more likely neglect referring patients to specialist. Patients with significant obesity and obesity related conditions are more likely to have proactive treatment plans by their FPs.

Identifiants

pubmed: 31646850
pii: S1121-421X.19.02618-7
doi: 10.23736/S1121-421X.19.02618-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

255-258

Auteurs

Amir Mari (A)

Section of Gastroenterology, Liver Unit, Nazareth Hospital, Nazareth, Israel - amir.mari@hotmail.com.
Faculty of Medicine, Bar Ilan University, Ramat Gan, Israel - amir.mari@hotmail.com.

Sohaib Omari (S)

Department of Internal Medicine, Nazareth Hospital, Nazareth, Israel.

Fadi Abu Baker (F)

Department of Gastroenterology, Liver Unit, Hilell Yaffe Medical Center, Hadera, Israel.

Saif Abu Much (S)

Department of Gastroenterology, Liver Unit, Hilell Yaffe Medical Center, Hadera, Israel.

Helal Said Ahmad (H)

Section of Gastroenterology, Liver Unit, Nazareth Hospital, Nazareth, Israel.

Tawfik Khoury (T)

Section of Gastroenterology, Liver Unit, Nazareth Hospital, Nazareth, Israel.
Faculty of Medicine, Bar Ilan University, Ramat Gan, Israel.

William Nseir (W)

Department of Internal Medicine, Nazareth Hospital, Nazareth, Israel.

Mahmud Mahamid (M)

Section of Gastroenterology, Liver Unit, Nazareth Hospital, Nazareth, Israel.
Faculty of Medicine, Bar Ilan University, Ramat Gan, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH